97016539

Information

• Trademark
• 97016539

• Source

• Serial Number

  97016539

• International Classifications

  • 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
  • 35 - Advertising
  • 40 - Treatment of materials
  • 41 - Education
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  September 08, 2021
  3 years ago

• Transaction Date

  December 20, 2024
  3 days ago

• Status Date

  June 20, 2024
  6 months ago

• Published for Opposition Date

  April 25, 2023
  a year ago

• Location Date

  June 20, 2023
  a year ago

• First Use Anywhere Date

  August 01, 2008
  16 years ago

• First Use In Commerce Date

  August 01, 2008
  16 years ago

• Status Code

  731

• Current Location

  INTENT TO USE SECTION

  Employee Name

  JOHNSON, DANYTHE

• Attorney Docket Number

  032808.0100

  Attorney Name

  Devon E. White

  Law Office Assigned Location Code

  N20

• Owners

  • INVICRO, LLC

Case File Statements

• GS0411: Educational services, namely, developing, arranging and conducting educational programs, panel discussions and non-downloadable webinars in the fields of pharmaceuticals, biotechnology, pre-clinical and clinical trials, and medical research; educational services, namely, providing non-downloadable publications in the nature of blogposts and magazines, and non-downloadable literature in the nature of periodicals and books in the fields of pharmaceuticals, biotechnology, pre-clinical and clinical trials, and medical research
• GS0401: Processing of medical images, namely, labeling, alteration and retouching of medical photographic images
• DM0000: The mark consists of an image of an overhead shot of a magnifying glass with a loupe in the circle.
• GS0091: Downloadable computer software for processing, visualizing, storing and analyzing pre-clinical and clinical radiology and pathology image data in the fields of drug development and disease research; downloadable computer software for image data management purposes, namely, pre-clinical and clinical image database management and research subject records management; downloadable computer software for processing multi-modal imaging data; downloadable computer software for the processing, storage and analysis of multi-modal imaging data for quantitation and evaluation of biomarkers and drug candidates; downloadable software for the assessment of tumors for research through use of biomarkers
• GS0351: Medical and scientific research, namely, conducting pre-clinical trial services for others in the nature of recruitment advertising services in the nature of posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs
• GS0441: Medical imaging services; medical imaging and radiology services related to drug development, namely, medical imaging and radiology services of clinical trial patients for medical purposes; image analysis and radiology, namely, analysis of images from all radiological modalities, such as but not limited to CT, MRI and PET scans to provide quantitative evaluation of drug candidates medical radiology, namely, molecular imaging, imaging utilizing radiopharmaceuticals for the diagnosis and medical treatment of trial candidates; radiomics, namely, medical radiology services; medical imaging services, namely, medical imaging and extraction of imaging biomarkers; analysis of medical images, namely, medical analysis of medical images for diagnosis and treatment of persons in clinical trials
• GS0421: Medical and scientific research, namely, conducting clinical trial services for others and pre-clinical trial services for others in the nature of testing of pharmaceuticals; pharmaceutical research and development services; testing of pharmaceutical pharmacodynamics, pharmacokinetics and efficacy using a variety of imaging modalities and imaging analysis platforms; imaging services and pathology in support of pharmaceutical research and development, namely, research of disease and non-medical ultrasound imaging services, all for the research and development of pharmaceuticals; drug discovery services; conducting early evaluations in the field of new drugs; scientific investigations for medical research purposes; medical and scientific research laboratory services; medical and scientific research, namely, providing analysis of imaging data obtained from pre-clinical and clinical trial studies; medical and scientific research in the fields of medical radiology imaging, pathology and digital pathology; providing medical and scientific research information in the fields of pharmaceuticals and biotechnology; research and development in the fields of medical imaging, pharmaceuticals and biotechnology; design, development, maintenance and updating of computer software for image processing, storage and analysis in the fields of pharmaceuticals and biotechnology; electronic storage of medical images; processing of medical images, namely, digital image interpretation for scientific research and medical research purposes, labeling, correction, restoration and enhancement; pathology services in support of drug development, namely, medical research regarding diseases for the purpose of developing drugs; hosting of a medical imaging analysis and visualization platform in the nature of a website through a global computer network; hosting of digital content on the Internet, namely, hosting of a database of medical images; software as a service (SAAS) featuring computer software platforms for image processing, storage and analysis in the fields of pharmaceuticals and biotechnology; conducting clinical trials for others at all stages and in various indications, particularly in oncology, neurology and systemic diseases; imaging contract research organization services and technology solutions, namely, non-medical ultrasound imaging services for medical and scientific research purposes and technology solutions, namely, reviewing of radiology images throughout the clinical trial process and blinded independent central review of radiology images in the medical research and clinical trial setting for medical research and scientific research purposes; scientific research services, namely, integration of imaging results with clinical outcome data, with application of machine learning and artificial intelligence applications; development and evaluation in the nature of testing of imaging biomarkers for clinical trial purposes; software consulting services in the field of drug discovery; cloud computing featuring software for use in database management for use in pharmaceutical drug research in the field of drug discovery; radiochemistry services in the nature of radiolabeling for scientific research and medical research purposes and radiochemical analysis; research, development and testing services relating to radiopharmaceuticals; radiolabeling scientific research, namely, labeling of both small molecules and biologics; providing non-downloadable web-based computer software for database management in the fields of medical imaging, pharmaceutical and biotechnology research; medical imaging and radiology services related to drug development, namely, medical imaging and radiology services of clinical trial patients for research purposes; medical and scientific research services in the fields of magnetic resonance and molecular imaging; medical research services, in particular services relating to the development of radiotherapeutics and drug candidates for neurodegenerative diseases and precision oncology; image analysis and radiology, namely, analysis of images from all radiological modalities, such as but not limited to CT, MRI and PET scans, to provide quantitative evaluation of drug candidates medical radiology, namely, molecular imaging, imaging utilizing radiopharmaceuticals for medical research and pharmaceutical development purposes; pathology services, namely, testing for research purposes in the fields of pharmaceuticals and biotechnology; pathology services for preclinical biomarker discovery research and clinical trials

Case File Event Statements

• 9/11/2021 - 3 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 10/18/2021 - 3 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 10/19/2021 - 3 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 6/13/2022 - 2 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 6/29/2022 - 2 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 6/29/2022 - 2 years ago

  6 - NON-FINAL ACTION E-MAILED Type: GNRT

• 6/29/2022 - 2 years ago

  7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 12/6/2022 - 2 years ago

  9 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 12/6/2022 - 2 years ago

  8 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 12/6/2022 - 2 years ago

  10 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 12/6/2022 - 2 years ago

  11 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 12/6/2022 - 2 years ago

  12 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 12/29/2022 - a year ago

  13 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 1/11/2023 - a year ago

  14 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 1/11/2023 - a year ago

  15 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 1/11/2023 - a year ago

  16 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 1/11/2023 - a year ago

  17 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 1/11/2023 - a year ago

  18 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 3/11/2023 - a year ago

  19 - ASSIGNED TO LIE Type: ALIE

• 3/13/2023 - a year ago

  20 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 3/13/2023 - a year ago

  21 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 3/17/2023 - a year ago

  22 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 3/17/2023 - a year ago

  23 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 3/17/2023 - a year ago

  24 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 3/17/2023 - a year ago

  25 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 3/17/2023 - a year ago

  26 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 4/5/2023 - a year ago

  27 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 4/25/2023 - a year ago

  29 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 4/25/2023 - a year ago

  28 - PUBLISHED FOR OPPOSITION Type: PUBO

• 6/20/2023 - a year ago

  30 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 12/15/2023 - a year ago

  34 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 12/13/2023 - a year ago

  31 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 12/13/2023 - a year ago

  32 - SOU EXTENSION 1 FILED Type: EXT1

• 12/13/2023 - a year ago

  33 - SOU EXTENSION 1 GRANTED Type: EX1G

• 5/22/2024 - 7 months ago

  35 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED Type: WOAR

• 5/22/2024 - 7 months ago

  36 - WITHDRAWAL OF ATTORNEY GRANTED Type: WOAG

• 6/13/2024 - 6 months ago

  40 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 6/13/2024 - 6 months ago

  41 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 6/13/2024 - 6 months ago

  38 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 6/13/2024 - 6 months ago

  37 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 6/13/2024 - 6 months ago

  39 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 6/20/2024 - 6 months ago

  42 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 6/20/2024 - 6 months ago

  45 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 6/20/2024 - 6 months ago

  43 - SOU EXTENSION 2 FILED Type: EXT2

• 12/19/2024 - 4 days ago

  47 - TEAS STATEMENT OF USE RECEIVED Type: EISU

• 12/19/2024 - 4 days ago

  46 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 6/20/2024 - 6 months ago

  44 - SOU EXTENSION 2 GRANTED Type: EX2G